MEDIUM confidence: 100% data completeness, but the composite (60) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Net insider -$2.3M over 180 days (1 open-market buys, 3 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Avg target $381 (last qtr, 3 analysts) → $381 (last mo, 3) (+0.0%).
Buy-rated share 56% → 50% over ~3 months (-6pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Oct 2026 | $5.57 | $5.77 | +3.6% |
| Jun 2026 | $5.17 | $5.31 | +2.7% |
| Apr 2026 | $4.00 | $4.14 | +3.5% |
| Jan 2026 | $4.52 | $4.69 | +3.8% |
| Oct 2025 | $4.83 | $5.20 | +7.7% |
| Jun 2025 | $4.44 | $5.12 | +15.3% |
| Apr 2025 | $3.69 | $3.73 | +1.1% |
| Jan 2025 | $3.87 | $3.97 | +2.6% |
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth below the analyst consensus of 4.7%/yr (revenue basis).
Base free cash flow $612M (avg FY2024–FY2026; latest year $748M) · equity value $9.4B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
| Metric (USD) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $4.0B— | $4.0B-1.3% | $3.8B-2.8% | $4.3B+13.1% | $4.6B+6.8% |
| EPS (dil.) | $11.08— | $10.76-2.9% | $13.44+24.9% | $12.53-6.8% | $17.05+36.1% |
| Free Cash Flow | $260M— | $511M+96.8% | $555M+8.6% | $533M-4.0% | $748M+40.3% |
| Gross Margin | 41.8% | 43.3%+1.6pp | 46.4%+3.0pp | 47.8%+1.4pp | 50.6%+2.8pp |
| Operating Margin | 12.7% | 12.0%-0.7pp | 14.4%+2.4pp | 13.7%-0.7pp | 15.9%+2.2pp |
| Net Margin | 9.6% | 8.8%-0.8pp | 11.0%+2.2pp | 9.1%-1.9pp | 11.4%+2.3pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
The QScore of 60 indicates a moderately attractive stock, driven by strong value and risk scores, with a P/E of 18.0 and beta of 1.3. Growth and momentum scores are somewhat lower, reflecting revenue growth of 6.8% and a 12-month return of -12.0%. Profitability scores are also moderate, with an ROE of 18.5% and gross margin of 50.6%. The long-term and short-term scores are closely aligned, suggesting a consistent outlook for the stock.